Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk
Yuetiva K. Deming, Eva Vasiljevic, Autumn Rose Morrow, Jiacheng Miao, Carol Van Hulle, Erin McMullen Jonaitis, Yue Ma, Vanessa M Whitenack, Gwendlyn Kollmorgen, Norbert Wild, Ivonne Suridjan, Leslie M. J. Shaw, Sanjay Asthana, Cynthia M. Carlsson, Sterling C. Johnson, , the Alzheimer's Disease Neuroimaging Initiative
The paper develops an APOE genetic risk score based on neuropathology that better explains CSF biomarker variance than traditional APOE ε4 metrics.
Alzheimer s & Dementia · Feb 16, 2023Peer-reviewedGenetic & Genomic Medicine